This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The interventions under study were: tonsillectomy with or without adenoidectomy (surgical interventions took place within 12 weeks of randomisation with preference to surgery according to local wait times at participating hospitals); and medical management (patients managed by their family doctor according to usual practice).
Location/setting
UK/Secondary in-patient care and primary care.
Methods

Analytical approach:
The economic analysis was based on a comprehensive cohort study in which patients were offered the possibility to enter a randomised controlled trial (where they were randomised either to surgery or usual practice). The time horizon was two years. The perspective was that of the National Health Service (NHS).
Effectiveness data:
Effectiveness data were derived from a randomised trial and a non-randomised study from an overall cohort study. A detailed report of the study methodology and full results had been published elsewhere (see Other Publications of Related Interest). Recruitment into the study was from 2002 to 2006. Patients were offered the possibility to enter a randomised controlled trial (where they were randomised either to surgery or usual practice). Those who declined participation in the trial were offered their preferred treatment and invited to participate in the parallel non-randomised study. Of the 1,546 children who were eligible for the study, 729 were enrolled: 268 in the randomised controlled trial and 461 in the non-randomised cohort study. The main effectiveness measure was episodes of sore throat defined as a minimum of three consecutive days of sore throat. This information was collected using 24 one-month structured sore throat health diaries completed by patients daily and returned monthly. At three, 12 and 24 months patients were assessed using the PedsQL (Pediatric Quality of Life) inventory with two generic core scales for physical and psychosocial health.
Monetary benefit and utility valuations:
None.
